Data on cost-efficacy and cost-benefit analysis of dengue control programs in Latin America are scarce; however, the cost per DALY averted by control programs during endemic periods appears low, as co
Research gap analysis derived from 3 medicine papers in our local library.
The gap
Data on cost-efficacy and cost-benefit analysis of dengue control programs in Latin America are scarce; however, the cost per DALY averted by control programs during endemic periods appears low, as compared to other mosquito-borne diseases
Consensus across the literature
Clustered from 3 gap mentions across 3 papers via embedding cosine ≥ 0.62.
Research trend
Established — well-defined area with open sub-problems.
Supporting evidence — 3 representative gaps
- Spectrum of Clinical Profile of Dengue Syndrome Admitted in Dengue Referral Center (2026) · doi
The study was conducted in a single referral center with a relatively small sample size. So the results may not represent the whole community. is consistent with recent observations CONCLUSION Dengue infection presents with a wide range of clinical manifestations among hospitalized patients. In this study, fever, headache, myalgia, and arthralgia were the most common presenting symptoms. Notably, gastrointestinal manifestations were prominent, with diarrhea emerging as one of the most frequent clinical features, while cutaneous manifestations such as rash were observed less frequently.
Keywords: manifestations clinical conducted single referral center relatively small sample size represent whole community consistent recent - Clinical characteristics and outcomes of dengue-associated transverse myelitis: A systematic review of case reports (2026) · doi
This review has important limitations. The evidence base consists entirely of case reports, which are vulnerable to publication bias, selective reporting, and heterogeneity in diagnostic evaluation and outcome assessment. Variability in diagnostic criteria and incomplete exclusion of alter- native causes introduce potential misclassification bias. Dengue serotype, autoimmune testing, standardized dis- ability scores and duration of follow-up were inconsistently reported, limiting mechanistic inference and prognosis stratification. The most frequently unmet quality criterion was explicit reporting of adverse events, which may have led to underestimation of treatment-related complications. Because case reports do not allow estimation of incidence or comparative treatment efficacy, causal inferences remain limited.
Keywords: case reports bias reporting diagnostic treatment review important limitations evidence base consists entirely vulnerable publication - The health and economic impact of dengue in Latin America (2007) · doi
Data on cost-efficacy and cost-benefit analysis of dengue control programs in Latin America are scarce; however, the cost per DALY averted by control programs during endemic periods appears low, as compared to other mosquito-borne diseases like yellow fever, leishmaniasis, or malaria.
Keywords: cost control programs efficacy benefit dengue latin america scarce daly averted endemic periods appears compared
Explore this gap further
Search “Data on cost-efficacy and cost-benefit analysis of dengue control programs in Latin America are scarce; however, the cost per DALY averted by control programs during endemic periods appears low, as co” across open scholarly engines for the latest related literature.
Working on this gap? Publish with us.
Science AI Journal reviews manuscripts in under 15 minutes with 8 specialised AI reviewers calibrated on 23,000+ real peer reviews. Open access, CC BY 4.0.
Free tools for your next paper
Related gaps in Medicine
- Recent literature from 2025 to 2026 has firmly established AI as a core driver in the methodological evolution of precision oncology for HCC. By implementing VFMs to mitigate imaging domain shifts andRecent literature from 2025 to 2026 has firmly established AI as a core driver in the methodological evolution of precision oncology for HCC.…
- Importance: Dual antiplatelet therapy has been demonstrated to be superior to single antiplatelet in reducing recurrent stroke among patients with transient ischemic attack or minor stroke, but robustImportance: Dual antiplatelet therapy has been demonstrated to be superior to single antiplatelet in reducing recurrent stroke among patient…
- External validation is required before the model can be applied in clinical settings.External validation is required before the model can be applied in clinical settings.
- Integration of AI literacy into clinical education and regulatory frameworks is needed for responsible implementation.Integration of AI literacy into clinical education and regulatory frameworks is needed for responsible implementation.